Further solidifying its leadership in myopia management, CooperVision has published a comprehensive global impact report detailing the critical role of MiSight® 1 day contact lenses in addressing myopia.1
Drawing on cross-regional data and collaborations with leading researchers and eye care professionals (ECPs), the Progress in Focus: The Global Impact of MiSight® 1 day2 report delivers the most comprehensive view to date of myopia’s global implications and the measurable difference MiSight® 1 day has made on children’s lives.1 It highlights advances in awareness, clinical adoption, and patient outcomes, underscoring CooperVision’s leadership and influence while celebrating past achievements and charting the path forward.
Read the full report to learn more:
